NCT01349660 2020-06-17Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma MultiformeSCRI Development Innovations, LLCPhase 1/2 Completed88 enrolled 13 charts